- Certara Appoints New Chief Human Resources Officer & General Counsel
- Certara Reports First Quarter 2024 Financial Results
- Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
- Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
- Certara Reports Fourth Quarter 2023 Financial Results
- Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
- Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
- Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
- Certara Reports Third Quarter 2023 Financial Results
- Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
More ▼
Key statistics
As of last trade, Certara Inc (CERT:NSQ) traded at 16.75, 41.83% above the 52 week low of 11.81 set on Nov 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 16.65 |
---|---|
High | 16.79 |
Low | 16.59 |
Bid | 16.73 |
Offer | 16.77 |
Previous close | 16.53 |
Average volume | 510.26k |
---|---|
Shares outstanding | 160.84m |
Free float | 119.70m |
P/E (TTM) | -- |
Market cap | 2.66bn USD |
EPS (TTM) | -0.3857 USD |
Data delayed at least 15 minutes, as of May 24 2024 14:41 BST.
More ▼